onr:"swepub:oai:openarchive.ki.se:10616/45492"
Search: onr:"swepub:oai:openarchive.ki.se:10616/45492" > Sequencing-based br...
- 1 of 1
- Previous record
- Next record
- To hitlist
Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers
-
- Rantalainen, Mattias (author)
- Karolinska Institutet
- Klevebring, Daniel (author)
-
- Lindberg, Johan (author)
- Karolinska Institutet
- show more...
- Ivansson, Emma (author)
- Rosin, Gustaf (author)
- show less...
- show more...
- (creator_code:org_t)
- show less...
- ISSN 2045-2322
- 2016-11-30
- 2016
- English.
- In: Scientific Reports. - Stockholm : Karolinska Institutet, Dept of Medical Epidemiology and Biostatistics. - 2045-2322.
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Sequencing-based breast cancer diagnostics have the potential to replace routine biomarkers and provide molecular characterization that enable personalized precision medicine. Here we investigate the concordance between sequencing-based and routine diagnostic biomarkers and to what extent tumor sequencing contributes clinically actionable information. We applied DNA- and RNA-sequencing to characterize tumors from 307 breast cancer patients with replication in up to 739 patients. We developed models to predict status of routine biomarkers (ER, HER2,Ki-67, histological grade) from sequencing data. Non-routine biomarkers, including mutations in BRCA1, BRCA2 and ERBB2(HER2), and additional clinically actionable somatic alterations were also investigated. Concordance with routine diagnostic biomarkers was high for ER status (AUC = 0.95;AUC(replication) = 0.97) and HER2 status (AUC = 0.97;AUC(replication) = 0.92). The transcriptomic grade model enabled classification of histological grade 1 and histological grade 3 tumors with high accuracy (AUC = 0.98;AUC(replication) = 0.94). Clinically actionable mutations in BRCA1, BRCA2 and ERBB2(HER2) were detected in 5.5% of patients, while 53% had genomic alterations matching ongoing or concluded breast cancer studies. Sequencing-based molecular profiling can be applied as an alternative to histopathology to determine ER and HER2 status, in addition to providing improved tumor grading and clinically actionable mutations and molecular subtypes. Our results suggest that sequencing-based breast cancer diagnostics in a near future can replace routine biomarkers
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Scientific Reports (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Rantalainen, Mat ...
- Klevebring, Dani ...
- Lindberg, Johan
- Ivansson, Emma
- Rosin, Gustaf
- Kis, Lorand
- show more...
- Celebiouglu, Fua ...
- Fredriksson, Irm ...
- Czene, Kamila
- Frisell, Jan
- Hartman, Johan
- Bergh, Jonas
- Grönberg, Henrik
- show less...
- Articles in the publication
- Scientific Repor ...
- By the university
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
